Petrović, Danijela

Link to this page

Authority KeyName Variants
50600093-419d-49e5-bd65-4c60b7437141
  • Petrović, Danijela (1)
Projects

Author's Bibliography

Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats

Petrović, Danijela; Seke, Mariana; Labudović-Borović, Milica; Jović, Danica; Borisev, Ivana; Srdjenović, Branislava; Rakocević, Zlatko; Pavlović, Vladimir; Djordjević, Aleksandar

(Academic Press Inc Elsevier Science, San Diego, 2018)

TY  - JOUR
AU  - Petrović, Danijela
AU  - Seke, Mariana
AU  - Labudović-Borović, Milica
AU  - Jović, Danica
AU  - Borisev, Ivana
AU  - Srdjenović, Branislava
AU  - Rakocević, Zlatko
AU  - Pavlović, Vladimir
AU  - Djordjević, Aleksandar
PY  - 2018
UR  - http://aspace.agrif.bg.ac.rs/handle/123456789/4794
AB  - In our recent studies we have designed fullerenol/doxorubicin nanocomposite (FNP/DOX) as the new drug nanocarrier. This research has demonstrated that this novel nanocomposite has had better implications on the liver tissue in vivo (Wistar rats treated intraperitoneally), than treatment based only on DOX. FNP/DOX has been characterised by DLS, TEM and AFM measurements which have shown that DOX loaded onto FNP did not influence fullerenol nanoparticle's size. FNP/DOX affected oxidative status in blood causing a significant decrease of catalase and SOD activity in comparison to DOX, implicating the reduction in oxidative stress. qRT-PCR results on the mRNA level of antioxidative enzymes (catalase and MnSOD) revealed that the effect of oxidative stress is significantly reduced by the treatment with FNP/DOX (p lt .05). The ultrastructural analysis of the liver tissue has revealed that FNP/DOX nanocomposite generated considerably less damage in the liver tissue, than DOX applied at the same dose. Hence, our results have indicated that FNP, within FNP/DOX nanocomposite, exhibits protective effects to the liver tissue of the healthy rats.
PB  - Academic Press Inc Elsevier Science, San Diego
T2  - Experimental and Molecular Pathology
T1  - Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats
EP  - 211
IS  - 3
SP  - 199
VL  - 104
DO  - 10.1016/j.yexmp.2018.04.005
ER  - 
@article{
author = "Petrović, Danijela and Seke, Mariana and Labudović-Borović, Milica and Jović, Danica and Borisev, Ivana and Srdjenović, Branislava and Rakocević, Zlatko and Pavlović, Vladimir and Djordjević, Aleksandar",
year = "2018",
abstract = "In our recent studies we have designed fullerenol/doxorubicin nanocomposite (FNP/DOX) as the new drug nanocarrier. This research has demonstrated that this novel nanocomposite has had better implications on the liver tissue in vivo (Wistar rats treated intraperitoneally), than treatment based only on DOX. FNP/DOX has been characterised by DLS, TEM and AFM measurements which have shown that DOX loaded onto FNP did not influence fullerenol nanoparticle's size. FNP/DOX affected oxidative status in blood causing a significant decrease of catalase and SOD activity in comparison to DOX, implicating the reduction in oxidative stress. qRT-PCR results on the mRNA level of antioxidative enzymes (catalase and MnSOD) revealed that the effect of oxidative stress is significantly reduced by the treatment with FNP/DOX (p lt .05). The ultrastructural analysis of the liver tissue has revealed that FNP/DOX nanocomposite generated considerably less damage in the liver tissue, than DOX applied at the same dose. Hence, our results have indicated that FNP, within FNP/DOX nanocomposite, exhibits protective effects to the liver tissue of the healthy rats.",
publisher = "Academic Press Inc Elsevier Science, San Diego",
journal = "Experimental and Molecular Pathology",
title = "Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats",
pages = "211-199",
number = "3",
volume = "104",
doi = "10.1016/j.yexmp.2018.04.005"
}
Petrović, D., Seke, M., Labudović-Borović, M., Jović, D., Borisev, I., Srdjenović, B., Rakocević, Z., Pavlović, V.,& Djordjević, A.. (2018). Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats. in Experimental and Molecular Pathology
Academic Press Inc Elsevier Science, San Diego., 104(3), 199-211.
https://doi.org/10.1016/j.yexmp.2018.04.005
Petrović D, Seke M, Labudović-Borović M, Jović D, Borisev I, Srdjenović B, Rakocević Z, Pavlović V, Djordjević A. Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats. in Experimental and Molecular Pathology. 2018;104(3):199-211.
doi:10.1016/j.yexmp.2018.04.005 .
Petrović, Danijela, Seke, Mariana, Labudović-Borović, Milica, Jović, Danica, Borisev, Ivana, Srdjenović, Branislava, Rakocević, Zlatko, Pavlović, Vladimir, Djordjević, Aleksandar, "Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats" in Experimental and Molecular Pathology, 104, no. 3 (2018):199-211,
https://doi.org/10.1016/j.yexmp.2018.04.005 . .
16
10
16